WO2010049078A8 - Verwendung von helium-sauerstoff-gasgemischen zur behandlung der pulmonalen arteriellen hypertonie - Google Patents

Verwendung von helium-sauerstoff-gasgemischen zur behandlung der pulmonalen arteriellen hypertonie Download PDF

Info

Publication number
WO2010049078A8
WO2010049078A8 PCT/EP2009/007488 EP2009007488W WO2010049078A8 WO 2010049078 A8 WO2010049078 A8 WO 2010049078A8 EP 2009007488 W EP2009007488 W EP 2009007488W WO 2010049078 A8 WO2010049078 A8 WO 2010049078A8
Authority
WO
WIPO (PCT)
Prior art keywords
gas mixtures
helium
oxygen gas
arterial hypertension
pulmonary arterial
Prior art date
Application number
PCT/EP2009/007488
Other languages
English (en)
French (fr)
Other versions
WO2010049078A1 (de
Inventor
Hubert Truebel
Eva-Maria Becker
Stefan Schäfer
Katja SCHÄFER
Jürgen KOHLMEYER
Original Assignee
Bayer Schering Pharma Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to BRPI0919980A priority Critical patent/BRPI0919980A2/pt
Priority to CA2741706A priority patent/CA2741706A1/en
Priority to US13/126,639 priority patent/US20120003325A1/en
Priority to AU2009310107A priority patent/AU2009310107A1/en
Priority to CN2009801534107A priority patent/CN102271689A/zh
Priority to MX2011004515A priority patent/MX2011004515A/es
Application filed by Bayer Schering Pharma Aktiengesellschaft filed Critical Bayer Schering Pharma Aktiengesellschaft
Priority to JP2011533579A priority patent/JP2012506881A/ja
Priority to EP09748704A priority patent/EP2349290A1/de
Priority to RU2011121520/15A priority patent/RU2011121520A/ru
Publication of WO2010049078A1 publication Critical patent/WO2010049078A1/de
Priority to IL212457A priority patent/IL212457A0/en
Publication of WO2010049078A8 publication Critical patent/WO2010049078A8/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Inorganic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Die vorliegende Anmeldung betrifft die Verwendung von Helium-Sauerstoff-Gasgemischen zur Behandlung und/oder Prophylaxe primärer und sekundärer Formen der pulmonalen Hypertonie (PH) sowie die Kombination von Arzneimitteln mit Helium-Sauerstoff-Gasgemischen, wobei die Gasgemische als Trägergase zur Verbesserung der Einbringung eines Arzneimittels zur Behandlung und/oder Prophylaxe der pulmonalen Hypertonie dienen.
PCT/EP2009/007488 2008-10-31 2009-10-20 Verwendung von helium-sauerstoff-gasgemischen zur behandlung der pulmonalen arteriellen hypertonie WO2010049078A1 (de)

Priority Applications (10)

Application Number Priority Date Filing Date Title
CA2741706A CA2741706A1 (en) 2008-10-31 2009-10-20 Use of helium-oxygen gas mixtures for treating pulmonary arterial hypertension
US13/126,639 US20120003325A1 (en) 2008-10-31 2009-10-20 Use of helium-oxygen gas mixtures for treating pulmonary arterial hypertension
AU2009310107A AU2009310107A1 (en) 2008-10-31 2009-10-20 Use of helium-oxygen gas mixtures for treating pulmonary arterial hypertension
CN2009801534107A CN102271689A (zh) 2008-10-31 2009-10-20 氦-氧气体混合物用于治疗肺动脉高压的用途
MX2011004515A MX2011004515A (es) 2008-10-31 2009-10-20 Uso de mezclas gaseosas de helio y oxigeno para el tratamiento de la hipertension arterial pulmonar.
BRPI0919980A BRPI0919980A2 (pt) 2008-10-31 2009-10-20 uso de misturas de gás hélio-oxigênio para o tratamento de hipertonia arterial pulmonar
JP2011533579A JP2012506881A (ja) 2008-10-31 2009-10-20 肺動脈高血圧症の処置のためのヘリウム−酸素ガス混合物の使用
EP09748704A EP2349290A1 (de) 2008-10-31 2009-10-20 Verwendung von helium-sauerstoff-gasgemischen zur behandlung der pulmonalen arteriellen hypertonie
RU2011121520/15A RU2011121520A (ru) 2008-10-31 2009-10-20 Применение гелий-кислородных газовых смесей для лечения легочной артериальной гипертонии
IL212457A IL212457A0 (en) 2008-10-31 2011-04-26 Use of helium-oxygen gas mixtures for treating pulmonary arterial hypertension

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102008054205.9 2008-10-31
DE102008054205A DE102008054205A1 (de) 2008-10-31 2008-10-31 Verwendung von Helium-Sauerstoff-Gasgemischen zur Behandlung der pulmonalen arteriellen Hypertonie

Publications (2)

Publication Number Publication Date
WO2010049078A1 WO2010049078A1 (de) 2010-05-06
WO2010049078A8 true WO2010049078A8 (de) 2011-06-03

Family

ID=41416259

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2009/007488 WO2010049078A1 (de) 2008-10-31 2009-10-20 Verwendung von helium-sauerstoff-gasgemischen zur behandlung der pulmonalen arteriellen hypertonie

Country Status (13)

Country Link
US (1) US20120003325A1 (de)
EP (1) EP2349290A1 (de)
JP (1) JP2012506881A (de)
KR (1) KR20110081322A (de)
CN (1) CN102271689A (de)
AU (1) AU2009310107A1 (de)
BR (1) BRPI0919980A2 (de)
CA (1) CA2741706A1 (de)
DE (1) DE102008054205A1 (de)
IL (1) IL212457A0 (de)
MX (1) MX2011004515A (de)
RU (1) RU2011121520A (de)
WO (1) WO2010049078A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2919780B1 (de) * 2012-11-14 2018-08-01 BIAL - Portela & CA., S.A. 1,3-dihydroimidazol-2-thion-derivate zur verwendung bei der behandlung von pulmonaler arterieller hypertonie und lungenverletzungen
EP3053587A1 (de) 2015-02-05 2016-08-10 Linde AG Kombination von Stickoxid, Helium und Antibiotika zur Behandlung von bakteriellen Lungeninfektionen
CN107149781A (zh) * 2017-05-25 2017-09-12 苏州墨维电子科技有限公司 一种用于改变声音的气体配方及其使用方法
US20220000993A1 (en) 2020-07-06 2022-01-06 Torvald Ranta Foretagsjuridik AB Drug for use against the novel coronavirus disease, covid-19

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9502987D0 (en) * 1995-02-16 1995-04-05 Boc Group Plc Medical gas mixture
ES2210585T3 (es) * 1996-08-27 2004-07-01 Messer Griesheim Gmbh Medicamento que contiene hidrogeno.
DE19834047A1 (de) 1998-07-29 2000-02-03 Bayer Ag Substituierte Pyrazolderivate
DE19834044A1 (de) 1998-07-29 2000-02-03 Bayer Ag Neue substituierte Pyrazolderivate
FR2795644B1 (fr) * 1999-07-02 2004-07-30 Air Liquide Sante Int Utilisations therapeutiques d'un melange helium/oxygene, en particulier dans le traitement de l'asthme
DE19943635A1 (de) 1999-09-13 2001-03-15 Bayer Ag Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
DE19943634A1 (de) 1999-09-13 2001-04-12 Bayer Ag Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften
DE19943636A1 (de) 1999-09-13 2001-03-15 Bayer Ag Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften
DE19943639A1 (de) 1999-09-13 2001-03-15 Bayer Ag Dicarbonsäurederivate mit neuartigen pharmazeutischen Eigenschaften
ES2164614B1 (es) * 2000-09-06 2003-05-16 Soc Es Carburos Metalicos Sa Mezcla de helio y oxigeno con aplicacion terapeutica.
AR031176A1 (es) 2000-11-22 2003-09-10 Bayer Ag Nuevos derivados de pirazolpiridina sustituidos con piridina
DE10110750A1 (de) 2001-03-07 2002-09-12 Bayer Ag Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
DE10110749A1 (de) 2001-03-07 2002-09-12 Bayer Ag Substituierte Aminodicarbonsäurederivate
DE10220570A1 (de) 2002-05-08 2003-11-20 Bayer Ag Carbamat-substituierte Pyrazolopyridine

Also Published As

Publication number Publication date
IL212457A0 (en) 2011-06-30
AU2009310107A1 (en) 2010-05-06
KR20110081322A (ko) 2011-07-13
CA2741706A1 (en) 2010-05-06
EP2349290A1 (de) 2011-08-03
WO2010049078A1 (de) 2010-05-06
US20120003325A1 (en) 2012-01-05
MX2011004515A (es) 2011-05-24
CN102271689A (zh) 2011-12-07
BRPI0919980A2 (pt) 2015-12-15
DE102008054205A1 (de) 2010-05-06
RU2011121520A (ru) 2012-12-10
JP2012506881A (ja) 2012-03-22

Similar Documents

Publication Publication Date Title
WO2008003958A3 (en) Fused pyrimido compounds
WO2008033562A3 (en) Kinase inhibitor compounds
WO2008000951A3 (fr) Dérivés d'urees de tropane, leur préparation et leur application en thérapeutique
WO2007149907A3 (en) Pyrazoloquinazolinones as parp inhibitors
WO2007015017A3 (fr) Nouveaux derives de polyquinoleines et leur utilisation therapeutique
WO2009084024A3 (en) A process for the preparation of r-sit agliptin and its pharmaceutically acceptable salts thereof
WO2008046581A3 (de) Substituierte tetrahydropyrrolopyrazin-verbindungen als inhibitoren der monoaminwiederaufnahme und deren verwendung in arzeimitteln
IL180551A0 (en) Use of substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines in the treatment of nausea and vomiting
WO2009027346A3 (de) 17beta-hydroxysteroid-dehydrogenase-typ1-inhibitoren zur behandlung hormonabhängiger erkrankungen
EA201170753A1 (ru) Налмефена гидрохлорид дигидрат
WO2007144169A3 (de) Entacapone-derivatives
WO2008136394A1 (ja) ラクタム化合物の製造方法及びその製造中間体
WO2011062864A3 (en) Inhibitors of nox enzymes and methods of use thereof
WO2010049449A3 (en) Novel salts of sunitinib
WO2010049078A8 (de) Verwendung von helium-sauerstoff-gasgemischen zur behandlung der pulmonalen arteriellen hypertonie
MX2009010483A (es) 5-oxoisoxazoles como inhibidores de lipasas y fosfolipasas.
WO2008042841A3 (en) Docetaxel compositions
EP4279130A3 (de) Verwendung von fk506 zur behandlung von pulmonaler arterieller hypertonie
WO2008049922A3 (en) A new process for the preparation of montelukast
EA200702201A1 (ru) Рофлумиласт для лечения лёгочной гипертензии
WO2007144699A3 (en) Process for the preparation of alfuzosin
WO2009124733A8 (de) Substituierte sulfonamid-derivate
WO2010075086A3 (en) Pyrrolidinone inhibitors of pde-4
WO2008066770A3 (en) Ace2 activator compounds and methods of use thereof
WO2010014798A3 (en) Pyrimidotriazinediones and pyrimidopyrimidinediones and methods of using the same

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200980153410.7

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09748704

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2009748704

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 3030/DELNP/2011

Country of ref document: IN

Ref document number: 212457

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 2741706

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: MX/A/2011/004515

Country of ref document: MX

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2011533579

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2009310107

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 20117012299

Country of ref document: KR

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2011121520

Country of ref document: RU

ENP Entry into the national phase

Ref document number: 2009310107

Country of ref document: AU

Date of ref document: 20091020

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 13126639

Country of ref document: US

ENP Entry into the national phase

Ref document number: PI0919980

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20110429